A case of adult dermatomyositis treated with cyclosporin a

Rheumatology

Volumn 31, Issue 12, 1992, Pages 855-

  Pugh, M T ^a   Collins, N A ^a   Rai, A ^a   Hollinrake, K ^a   Coppock, J S ^a  

^a Hospital of Coventry and Warwickshire   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; CREATINE KINASE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; CREATININE CLEARANCE; DERMATOMYOSITIS; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAUNDICE; LETTER; LIVER TOXICITY; MUSCLE BIOPSY; ORAL DRUG ADMINISTRATION; POLYMYOSITIS; PRIORITY JOURNAL;

ADULT; CASE REPORT; CYCLOSPORINE; DERMATOMYOSITIS; FEMALE; HUMAN;

EID: 0026564278     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/31.12.855     Document Type: Letter

References (7)

1. Shevach EM. The effect of cyclosporin on the immune system. Annu Rev Immunol 1985;3:397.
2. Fauci AS, Young KR. Immunoregulatory agents. In: Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology, 3rd ed. Philadelphia: WB Saunders, 1989;879-81.
3. Zabel P, Eimstoll G, Gross WL. Cyclosporin for acute der-matomyositis (letter). Lancet 1984;i:343.
4. Ejustrup L. Severe dermatomyositis treated with cyclosporin A. Ann Rheum Dis 1986;4S:612-4.
5. Irschik E, Tilg H, Niederwieser D, Gastl G, Huber C, Mar-grieter R. Cyclosporin levels do correlate with clinical complications. Lancet 1984;11:692-3.
6. Levi S, Hodgson HJF. Cyclosporin for dermatomyositis? Ann Rheum Dis 1989;48:85-6.
7. Dantzig P. Juvenile dermatomyositis treated with cyclosporin. J Am Acad Dermatol 1990;22:310-11.